Alcon Gross Profit 2019-2022 | ALC
Alcon annual/quarterly gross profit history and growth rate from 2019 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Alcon gross profit for the quarter ending September 30, 2022 was $1.166B, a 2.43% decline year-over-year.
- Alcon gross profit for the twelve months ending September 30, 2022 was $4.784B, a 10.72% increase year-over-year.
- Alcon annual gross profit for 2021 was $4.652B, a 58.23% increase from 2020.
- Alcon annual gross profit for 2020 was $2.94B, a 19.72% decline from 2019.
- Alcon annual gross profit for 2019 was $3.662B, a 14.72% increase from 2018.
Alcon Annual Gross Profit (Millions of US $) |
2021 |
$4,652 |
2020 |
$2,940 |
2019 |
$3,662 |
2018 |
$3,192 |
Alcon Quarterly Gross Profit (Millions of US $) |
2022-09-30 |
$1,166 |
2022-06-30 |
$1,204 |
2022-03-31 |
$1,208 |
2021-12-31 |
$1,206 |
2021-09-30 |
$1,195 |
2021-06-30 |
$1,220 |
2021-03-31 |
$1,031 |
2020-12-31 |
$875 |
2020-09-30 |
$848 |
2020-06-30 |
$345 |
2020-03-31 |
$872 |
2019-12-31 |
$913 |
2019-09-30 |
$950 |
2019-06-30 |
$947 |
2019-03-31 |
$852 |
2018-12-31 |
|
2018-09-30 |
$568 |
2018-06-30 |
$878 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Instruments Manufacturing |
$37.369B |
$8.291B |
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|